News
The CDC's expert panel explores narrowing COVID-19 booster shot guidelines to focus on high-risk groups. Despite concerns ...
The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...
The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...
Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key ...
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...
Hosted on MSN23d
Did the U.S. get a bad deal on boosters? #medicine #moderna #vaccine #booster #covid19The U.S. government is going to pay a lot more for Covid-19 booster shots than it used to, and one Senator from Vermont is not happy about it. The read more, check out the full story at STAT ...
Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...
On a recent call with analysts at BMO Capital Markets, a “former director” at the FDA’s Center for Biologics Evaluation and ...
US CDC advisers discuss narrowing use of COVID-19 booster shots The U.S. Centers ... 2025 Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents Pfizer and BioNTech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results